Rosetta Genomics (ROSG) Reports Q4 Loss Per Share of $0.14

Rosetta Genomics (NASDAQ: ROSG) reported Q4 EPS of ($0.14). Revenue for the quarter came in at $3.6 million, versus $698 thousand reported last year.

For earnings history and earnings-related data on Rosetta Genomics (ROSG) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance
• Aspire Biopharma to acquire automotive supplier for $30 million